Shingrix vaccine shows added cardiovascular benefits over older shot
A study of over 72,000 older adults found that those receiving the newer Shingrix vaccine had lower rates of stroke and heart failure compared to those given the older Zostavax. The effect may stem from the AS01 adjuvant, which could dampen inflammation. This adds to evidence that shingles vaccination offers benefits beyond preventing the infection.
Related stories
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Shingles vaccine may lower risk of stroke and heart failure.” Browse more stories.